Product Information
SIKLOS 1,000 MG TABLET is a brand product labeled by Medunik, priced at $61.9959 per EA under NDC 71770012030. Its NADAC has been published 102 times since Oct 23, 2024.
FDA first approved this application on Dec 21, 2017.
The High Outlier badge above means this manufacturer's average price in the hydroxyurea market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
MedunikNDC
71770012030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYUREAApproval Type
New Drug (NDA)
FDA Application
NDA208843FDA Approved
12/21/2017
On Market Since
4/15/2018
Pharmacological Classes
Price Statistics
The NADAC for SIKLOS 1,000 MG TABLET has been published 102 times since Oct 23, 2024, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $61.9959 per EA |
|---|---|
| All-time high | $62.0318 (Sep 16, 2026) |
| All-time low | $58.3510 (Dec 18, 2024) |
| 52-week high | $62.0318 |
| 52-week low | $60.1718 |
| Median price | $60.3897 |
| Average price | $60.8035 |
| Largest weekly change | +3.5% (Jan 1, 2025) |
| Weeks tracked | 102 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydroxyurea market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medunik manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydroxyurea market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIKLOS 1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIKLOS 1,000 MG TABLET, manufactured by Medunik, is $61.9959 per EA (NDC 71770012030), effective Sep 30, 2026.
How has the price of SIKLOS 1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIKLOS 1,000 MG TABLET has risen 5.9%. It has been tracked across 102 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for SIKLOS 1,000 MG TABLET?
Since Oct 23, 2024, the NADAC for SIKLOS 1,000 MG TABLET has ranged from a low of $58.3510 (Dec 18, 2024) to a high of $62.0318 (Sep 16, 2026), with a median of $60.3897 per EA.
Are there cheaper alternatives to SIKLOS 1,000 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SIKLOS 1,000 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SIKLOS 1,000 MG TABLET?
SIKLOS 1,000 MG TABLET (NDC 71770012030) is labeled by Medunik, and CMS classifies it as a brand product.